Original language | English |
---|---|
Pages (from-to) | 1659-1724 |
Number of pages | 66 |
Journal | The Lancet |
Volume | 388 |
Issue number | 10053 |
DOIs | |
Publication status | Published - 8 Oct 2016 |
Externally published | Yes |
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: The Lancet, Vol. 388, No. 10053, 08.10.2016, p. 1659-1724.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015
T2 - a systematic analysis for the Global Burden of Disease Study 2015
AU - GBD 2015 Risk Collaborators
AU - Forouzanfar, M. H.
AU - Afshin, A.
AU - Alexander, L. T.
AU - Biryukov, S.
AU - Brauer, M.
AU - Cercy, K.
AU - Charlson, F. J.
AU - Cohen, A. J.
AU - Dandona, L.
AU - Estep, K.
AU - Ferrari, A. J.
AU - Frostad, J. J.
AU - Fullman, N.
AU - Godwin, W. W.
AU - Griswold, M.
AU - Hay, S. I.
AU - Kyu, H. H.
AU - Larson, H. J.
AU - Lim, S. S.
AU - Liu, P. Y.
AU - Lopez, A. D.
AU - Lozano, R.
AU - Marczak, L.
AU - Zhao, Y.
AU - Bell, B.
AU - Johnson, C. O.
AU - Thomas, B. A.
AU - Guo, Y.
AU - Li, Y.
AU - Liu, S.
AU - Wang, L.
AU - Alam, K.
AU - Taylor, H. R.
AU - Kemp, A. H.
AU - Leigh, J.
AU - Agarwal, A.
AU - Huang, J. J.
AU - Rahman, M. H.U.
AU - Singh, A.
AU - Khan, A. R.
AU - Khan, G.
AU - Levi, M.
AU - Li, X.
AU - Wang, J.
AU - Phillips, M. R.
AU - Rahman, M. H.U.
AU - Shaddick, G.
AU - Thomas, M. L.
AU - Wang, Y.
AU - Yu, C.
N1 - Funding Information: Bruce Bartholow Duncan and Maria Inês Schmidt have received additional funding from the Brazilian Ministry of Health (Process No 25000192049/2014-14). Benjamin O Anderson is supported by the Susan G Komen Leadership Grant Research Project, award number SAC160001. Itamar S Santos reports grants from FAPESP (Brazilian public agency), outside the submitted work. Carl Abelardo T Antonio reports grants, personal fees and non-financial support from Johnson & Johnson (Philippines), Inc, outside the submitted work. Kunihiro Matsushita reports personal fees from Mitsubishi Tanabe Pharma, Kyowa Hakko Kirin, and MSD outside of the submitted work. Rafael Tabarés-Seisdedos and Ferrán Catalá-López are supported in part by grant PROMETEOII/2015/021 from Generalitat Valenciana, and Rafael Tabarés-Seisdedos is supported by the national grant PI14/00894 from ISCIII-FEDER. Walter Mendoza is currently employed by the Peru Country Office of the United Nations Population Fund, an institution which does not necessarily endorse this study. Bradford D Gessner reports grants from Crucell, GSK, Hilleman Labs, Novartis, Pfizer, Merck, and Sanofi Pasteur, outside the submitted work. Ai Koyanagi's work is supported by the Miguel Servet contract financed by the CP13/00150 and PI15/00862 projects, integrated into the National R + D + I and funded by the ISCIII—General Branch Evaluation and Promotion of Health Research—and the European Regional Development Fund (ERDF-FEDER). Aletta E Schutte is funded by the Medical Research Council of South Africa, and the South African Research Chair Initiative by the National Research Foundation. Dariush Mozaffarian reports ad-hoc honoraria or consulting from Boston Heart Diagnostics, Haas Avocado Board, AstraZeneca, GOED, DSM, and Life Sciences Research Organization; and chapter royalties from UpToDate. Amador Goodridge would like to acknowledge funding for me from Sistema Nacional de Investigadores de Panamá-SNI. Donal Bisanzio is supported by Bill & Melinda Gates Foundation (#OPP1068048). Jost B Jonas reports personal fees from Consultant for Mundipharma Co (Cambridge, UK); from patent holder with Biocompatibles UK Ltd (Franham, Surrey, UK) (Title: Treatment of eye diseases using encapsulated cells encoding and secreting neuroprotective factor and / or anti-angiogenic factor; patent number: 20120263794), from patent application with University of Heidelberg (Heidelberg, Germany) (Title: Agents for use in the therapeutic or prophylactic treatment of myopia or hyperopia; Europäische Patentanmeldung 15 000 771.4), outside the submitted work. Rodrigo Sarmiento-Suarez receives institutional support from Universidad de Ciencias Aplicadas y Ambientales, UDCA, Bogotá Colombia. Juan A Rivera reports personal fees from Tres Montes Lucchetti, outside the submitted work. Stefanos Tyrovolas's work is supported by the Foundation for Education and European Culture (IPEP), the Sara Borrell postdoctoral programme (reference no CD15/00019 from the Instituto de Salud Carlos III (ISCIII - Spain) and the Fondos Europeo de Desarrollo Regional (FEDER). Beatriz Paulina Ayala Quintanilla would like to acknowledge the institutional support of PRONABEC (National Program of Scholarship and Educational Loan), provided by the Peruvian Government, while studying for her doctoral course at the Judith Lumley Centre of La Trobe University funded by PRONABEC. Manami Inoue is the beneficiary of a financial contribution from the AXA Research fund as chair holder of the AXA Department of Health and Human Security, Graduate School of Medicine, The University of Tokyo from Nov 1, 2012; the AXA Research Fund has no role in this work. Sarah C Darby would like to acknowledge Cancer Research UK (grant no C8225/A21133). Yogeshwar Kalkonde is a Wellcome Trust/ DBT India Alliance Intermediate Fellow in Public Health. Heidi Stöckl is funded by a British Academy Postdoctoral Fellowship. Tea Lallukka reports funding from The Academy of Finland, grant #287488. Charles D A Wolfe's research was funded/supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. Simon I Hay is funded by a Senior Research Fellowship from the Wellcome Trust (#095066), and grants from the Bill & Melinda Gates Foundation (OPP1119467, OPP1093011, OPP1106023, and OPP1132415). Publisher Copyright: © 2016 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license
PY - 2016/10/8
Y1 - 2016/10/8
UR - http://www.scopus.com/inward/record.url?scp=85060773959&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(16)31679-8
DO - 10.1016/S0140-6736(16)31679-8
M3 - Article
C2 - 27733284
AN - SCOPUS:85060773959
SN - 0140-6736
VL - 388
SP - 1659
EP - 1724
JO - The Lancet
JF - The Lancet
IS - 10053
ER -